148 related articles for article (PubMed ID: 3925762)
1. Clinical experience with cyclosporine and azathioprine at Brigham and Women's Hospital.
Milford EL; Kirkman RL; Tilney NL; Strom TB; Carpenter CB
Am J Kidney Dis; 1985 Jun; 5(6):313-7. PubMed ID: 3925762
[TBL] [Abstract][Full Text] [Related]
2. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Sutherland DE; Fryd DS; Strand MH; Canafax DM; Ascher NL; Payne WD; Simmons RL; Najarian JS
Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporine in renal transplantation: a single institutional experience.
Ferguson RM; Sommer BG
Am J Kidney Dis; 1985 Jun; 5(6):296-306. PubMed ID: 3925761
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS
Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
[TBL] [Abstract][Full Text] [Related]
5. Examination of parameters influencing the benefit:detriment ratio of cyclosporine in renal transplantation. The Canadian Transplant Study Group.
Am J Kidney Dis; 1985 Jun; 5(6):328-32. PubMed ID: 3925763
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
[TBL] [Abstract][Full Text] [Related]
7. A single institution, randomized, prospective trial of cyclosporin versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Najarian JS; Fryd DS; Strand M; Canafax DM; Ascher NL; Payne WD; Simmons RL; Sutherland DE
Ann Surg; 1985 Feb; 201(2):142-57. PubMed ID: 3882063
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
Chapman JR; Morris PJ
Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
[No Abstract] [Full Text] [Related]
9. A prospective randomised comparative study on the influence of cyclosporin and azathioprine on renal allograft survival and function.
Henny FC; Kootte AM; Van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC
Nephrol Dial Transplant; 1986; 1(1):44-9. PubMed ID: 3110662
[TBL] [Abstract][Full Text] [Related]
10. Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation.
Kupin WL; Venkatachalam KK; Oh HK; Dienst S; Levin NW
Transplantation; 1985 Dec; 40(6):601-4. PubMed ID: 3907029
[TBL] [Abstract][Full Text] [Related]
11. Outcome of cadaveric renal transplant patients treated for 10 years with cyclosporine: is chronic allograft nephropathy the major cause of late graft loss?
Marcén R; Pascual J; Teruel JL; Villafruela JJ; Rivera ME; Mampaso F; Burgos FJ; Ortuño J
Transplantation; 2001 Jul; 72(1):57-62. PubMed ID: 11468535
[TBL] [Abstract][Full Text] [Related]
12. HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function.
Sumrani N; Delaney V; Ding ZK; Butt K; Hong J
Am J Kidney Dis; 1990 Nov; 16(5):417-22. PubMed ID: 2239931
[TBL] [Abstract][Full Text] [Related]
13. Effective long-term immunosuppression maintained by low cyclosporine levels in primary cadaveric renal transplant recipients.
Kupin WL; Venkat KK; Norris C; Florence-Green D; Dienst S; Oh HK; Feldkamp C; Levin NW
Transplantation; 1987 Feb; 43(2):214-8. PubMed ID: 3544378
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine use in early graft dysfunction.
Gonwa TA; Nghiem DD; Schulak JA; Corry RJ
Transplant Proc; 1986 Apr; 18(2 Suppl 1):104-12. PubMed ID: 3515675
[No Abstract] [Full Text] [Related]
15. Comparison of azathioprine-antilymphocyte globulin versus cyclosporine in renal transplantation.
Sutherland DE; Strand M; Fryd DS; Ferguson RM; Simmons RL; Ascher NL; Najarian JS
Am J Kidney Dis; 1984 May; 3(6):456-61. PubMed ID: 6372449
[No Abstract] [Full Text] [Related]
16. Triple therapy in cadaver renal transplantation.
Jones RM; Murie JA; Allen RD; Ting A; Morris PJ
Br J Surg; 1988 Jan; 75(1):4-8. PubMed ID: 3276369
[TBL] [Abstract][Full Text] [Related]
17. Improved outcome of renal transplantation with cyclosporine compared with azathioprine--experience in 33 recipients followed for over one year.
Yasumura T; Ohmori Y; Aikawa I; Fukuda M; Suzuki S; Nakai I; Matsui S; Oka T
Jpn J Surg; 1986 May; 16(3):181-8. PubMed ID: 3525928
[TBL] [Abstract][Full Text] [Related]
18. The effect of cyclosporine on early graft function in human renal transplantation.
Flechner SM; Payne WD; Van Buren C; Kerman R; Kahan BD
Transplantation; 1983 Sep; 36(3):268-72. PubMed ID: 6351368
[TBL] [Abstract][Full Text] [Related]
19. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
20. Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
Kerman RH; Van Buren CT; Lewis RM; Kahan BD
Transplant Proc; 1988 Jun; 20(3 Suppl 3):264-9. PubMed ID: 3291254
[No Abstract] [Full Text] [Related]
[Next] [New Search]